Classification is the first decision in any SFDA registration, and it quietly shapes everything that follows: the route, the documents and the depth of review. SFDA sorts medical devices into Class A, B, C and D according to the risk they carry, using the rules in its guidance MDS-G008.
One letter, many consequences: why class comes first
Your class decides more than a label on a spreadsheet. It determines:
- Your registration route: Low-risk Class A devices may qualify for the Medical Device Listing (MDL) route. Class B, C and D devices need a full Medical Device Marketing Authorization (MDMA).
- Which Class A devices still need full review: Class A devices supplied sterile, with a measuring function, or that are reusable surgical instruments follow the MDMA route as well.
- What goes in the technical file: The documents SFDA expects grow with the risk class.
- Parts of your labelling: Under SFDA's essential principles, instructions for use are not required for Class A and Class B devices that can be used safely without them.
A wrong class has a way of showing up late. You build the file for one class, SFDA reads it as another, and the result is queries, rework and lost weeks. A day spent on classification at the start is the cheapest time you will spend on the whole project.
The classes at a glance
MDS-G008 lists seven categories for medical devices: Class A (with three variants), B, C and D. The examples below come from the guidance itself.
| Class | Risk level | Examples from MDS-G008 | Route |
|---|---|---|---|
| A | Low | Stethoscopes, corrective glasses, examination lights | MDL may apply |
| A, supplied sterile | Low-medium | Class A devices delivered sterile | MDMA |
| A, with a measuring function | Low-medium | Class A devices that measure | MDMA |
| A, reusable surgical instruments | Low-medium | Reusable surgical instruments (Rule 6) | MDMA |
| B | Low-medium | Single-use scalpels, surgical swabs, TENS devices, diagnostic ultrasound | MDMA |
| C | Medium-high | Blood bags, hemodialysers, dental implants placed in bone, lung ventilators, patient monitors | MDMA |
| D | High | Cardiovascular catheters, prosthetic heart valves | MDMA |
Note: Treat the examples as illustrations only. The guidance is clear that the manufacturer's stated intended use can change the class of any device on this list.
Behind the letters: how the 22 rules work
The rules look at a handful of questions about your device. How long is it used? How deep does it go into the body? Does it need an energy source? Where in the body does it sit? And above all: what is it meant to do?
Duration: MDS-G008 defines transient use as under 60 minutes, short-term as 60 minutes to 30 days, and long-term as more than 30 days. Continuous use includes short interruptions and immediate replacement with the same device.
Location: Contact with the central circulatory system or central nervous system raises the class. The same device can end up in different classes depending on the body part it is used in.
Energy: A device that depends on a power source other than the human body or gravity is active. Software that drives or influences a device is treated as active too.
The 22 rules then fall into four groups:
- Rules 1–4, non-invasive devices- Devices that touch intact skin, channel or store substances, modify blood or tissue, or contact injured skin.
- Rules 5–8, invasive devices- Devices entering through body orifices, and surgically invasive devices from transient use through to implants.
- Rules 9–13, active devices- Therapeutic and diagnostic equipment, software, and devices that administer or remove substances, with a fallback rule for the rest.
- Rules 14–22, special rules- Devices with a medicinal ingredient, contraception, disinfectants, X-ray image recording, animal or human tissue, nanomaterials, inhalation devices, substance-based devices, and active therapeutic devices with a diagnostic function.
When more than one rule applies, the strictest one wins. The guidance gives a collagen wound dressing as its example: it falls under both Rule 4 and Rule 18, so it is Class D.
IVDs have their own scale
In vitro diagnostic devices are classified separately, on two kinds of risk: the risk to the individual patient, and the risk to public health. SFDA applies seven rules to IVDs, again producing Classes A to D.
| Class | Individual risk | Public health risk |
|---|---|---|
| A | Low | Low |
| B | Moderate | Low |
| C | High | Moderate |
| D | High | High |
For Classes B and C, MDS-G008 describes the risk with "and/or" rather than requiring both. The IVD section also has its own implementing rules, covering software, calibrators, control materials, and first-line, confirmatory and supplemental assays. If you make an IVD, read that section on its own rather than assuming the device rules carry across.
Five steps to the right class
- Pin down the intended use- Write it exactly as it appears on your label, instructions for use, advertising and technical documentation. MDS-G008 treats all of these as evidence of what you intend.
- List the device characteristics- Note how long it is used, whether it is invasive, whether it is active or contains software, where in the body it sits, and whether it contains medicinal, animal-derived or nanomaterial components.
- Run every rule, not just the obvious one- Check the special rules (14–22) even when a general rule seems to fit. Where several apply, the strictest sets the class.
- Classify accessories and combinations separately- Each device in a combination, and each accessory, is classified in its own right.
- Write down your reasoning- Record which rules you applied, which you ruled out and why. That note becomes part of the technical file and saves you from re-deriving the answer under questioning.
If a device is not limited to one body part, the most critical specified use applies. You can avoid a higher class by stating clearly on the label which indications and body parts the device is, and is not, intended for. Only do this if it is true to how the device will actually be used.
Borrowing a class from another market? Read this first
It is tempting to take your EU or US class and carry it across. Use it as a sanity check, not as the answer. MDS-G008 states that the class comes from the manufacturer's intended use, not from the device's technical characteristics or from how similar devices are classified elsewhere.
The rule sets are close cousins, not copies. A few practical habits help:
- Compare the rules, not just the letters: If your SFDA class is different from your EU or US one, find the rule that drives it. The difference usually comes down to duration, body location or a special rule.
- Check the intended-use wording: A small difference in the claim can move a device from one rule to another.
- Look at reference-market classification early: Reviewing how the US, EU, Canada, Australia and Japan classify the device helps you spot a mismatch before SFDA does.
Where your class differs from the one you hold elsewhere, be ready to explain why. A short note in the file, tied to the rule, shows you have done the work.
Where classification goes wrong
Most errors come from the same few places.
- Classifying by device type instead of intended use: Two near-identical devices can sit in different classes if their intended uses differ.
- Stopping at the first rule that fits: The special rules (14–22) catch devices with animal tissue, nanomaterials, a medicinal ingredient or an inhalation function.
- Forgetting the body location: Contact with the central circulatory or nervous system changes the class.
- Overlooking software: Standalone software is classified under Rule 11, from Class A to Class D depending on the consequence of a wrong decision. Software that only records, stores or displays information is generally not a device.
- Treating accessories as part of the main device: They are classified in their own right.
- Letting marketing contradict the file: Advertising counts as evidence of intended use, so claims that go beyond your IFU can undo a carefully argued class.
Not sure where your device falls?
Send us your device description, intended use and the class you expect. We'll check it against the MDS-G008 rules, tell you plainly which SFDA class and route we think apply, and flag where the risks sit, before you commit to anything.
Request a classification review.